Riten Kumar: Diagnosis and Management of Post-Thrombotic Sequelae Following Non-Extremity VTE in Children
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, adding:
“Non-extremity thrombosis constitutes approximately 40% of pediatric VTE and is associated with significant long-term morbidity.
In this JTH review, we summarize the current evidence on the epidemiology, pathophysiology, and management of post-thrombotic sequelae following non-extremity VTE in children.”
Title: Non-Extremity Thrombosis Sequelae in Children: Screening, Diagnosis, and Management
Authors: Riten Kumar, Vilmarie Rodriguez, Clay Cohen, Madhvi Rajpurkar, Ayesha Zia
Read the Full Article on JTH
Find more posts featuring Riten Kumar on Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS